Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amedisys Inc Lowers FY 2013 Revenue Guidance; Reaffirms FY 2013 EPS Guidance

Wednesday, 31 Jul 2013 07:00am EDT 

Amedisys announced that for fiscal 2013, it expects net service revenue is anticipated to be in the range of $1.240 billion to $1.280 billion, diluted earnings per share is expected to be in the range of $0.45 to $0.55 based on an estimated 31.5 million shares outstanding. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.319 billion and EPS of $0.49 for fiscal 2013. 

Company Quote

0.15 +0.72%
29 Aug 2014